Tulipano Stephen J

CIK 00013605483 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001360548

Recent Transactions

50 trades

Award
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2024-03-27+40,000→ 40,000 total
Award
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2024-03-27+60,000→ 60,000 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-03-19$6.10/sh−4,116→ 20,746 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-03-15+13,100→ 24,862 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2024-03-15−13,100→ 39,300 total
Disposition to Issuer
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2023-12-01−65,600→ 0 total
Award
Stoke Therapeutics, Inc.$STOK
Restricted Stock Unit (RSU)
2023-12-01+60,773→ 60,773 total
Disposition to Issuer
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2023-12-01−107,400→ 0 total
Disposition to Issuer
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2023-12-01−60,000→ 0 total
Award
Stoke Therapeutics, Inc.$STOK
Restricted Stock Unit (RSU)
2023-03-15+52,400→ 52,400 total
Award
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2023-03-15+78,600→ 78,600 total
Award
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2022-12-07+62,000→ 62,000 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2022-06-02$4.48/sh+11,160→ 11,762 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2022-06-02−11,160→ 168,837 total
Award
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2022-03-15+107,400→ 107,400 total
Award
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2021-03-02+65,600→ 65,600 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-02-23$4.48/sh+5,000→ 5,602 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-02-23$58.60/sh−5,000→ 602 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2021-02-23−5,000→ 179,997 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-02-22$4.48/sh+25,000→ 25,602 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-02-22$59.29/sh−9,696→ 704 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2021-02-22−25,000→ 184,997 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-02-22$58.67/sh−15,202→ 10,400 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-02-22$60.00/sh−102→ 602 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2020-11-04$4.48/sh+33,268→ 33,870 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2020-11-04$40.03/sh−16,941→ 16,929 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2020-11-04$41.42/sh−11,111→ 5,818 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2020-11-04−33,268→ 209,997 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2020-11-04$41.97/sh−5,216→ 602 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2020-11-03$39.84/sh−1,732→ 602 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2020-11-03−1,732→ 243,265 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2020-11-03$4.48/sh+1,732→ 2,334 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2020-11-02$38.44/sh−400→ 602 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2020-11-02$37.86/sh−14,445→ 1,002 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2020-11-02−35,000→ 244,997 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2020-11-02$4.48/sh+35,000→ 35,602 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2020-11-02$36.79/sh−20,155→ 15,447 total
Award
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2020-03-25+60,000→ 60,000 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Employee Stock Option (Right to Buy)
2018-03-06+125,670→ 125,670 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2017-12-29$4.00/sh+3,153→ 8,563 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2017-06-30$3.95/sh+2,077→ 5,410 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Employee Stock Option (Right to Buy)
2017-03-03+220,980→ 220,980 total
Purchase
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2017-02-17$4.50/sh+3,333→ 3,333 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Employee Stock Option (Right to Buy)
2016-03-16+30,000→ 30,000 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Employee Stock Option (Right to Buy)
2015-06-03+25,000→ 25,000 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Employee Stock Option (Right to Buy)
2014-07-21+67,642→ 67,642 total
Disposition to Issuer
JAVELIN PHARMACEUTICALS, INC
Stock Option (right to buy)
2010-07-02−60,000→ 0 total
Disposition to Issuer
JAVELIN PHARMACEUTICALS, INC
Stock Option (right to buy)
2010-07-02−150,000→ 0 total
Disposition to Issuer
JAVELIN PHARMACEUTICALS, INC
Stock Option (right to buy)
2010-07-02−44,700→ 0 total
Disposition to Issuer
JAVELIN PHARMACEUTICALS, INC
Restricted Stock Units
2010-07-02$2.20/sh−12,500→ 0 total

Companies

Recent Filings

Address

C/O JAVELIN PHARMACEUTICALS 125 CAMBRIDGEPARK DRIVE

CAMBRIDGE, MA, 02140

View on SEC.gov